Facebook
Twitter
LinkedIn
ForwardASCO Direct™ Highlight: 2021 Official Annual Meeting Review
ASCO Direct™ Highlights: 2021 Official Annual Meeting Review, an officially licensed program of the American Society of Clinical Oncology® (ASCO®) is the 9th annual conference being organized by the Binaytara Foundation and features some of the most well-known experts in the field of hematology and oncology. A number of potentially practice-changing abstracts were presented during the 2021 ASCO Annual Meeting in June, 2021 (ASCO2021). Expert faculty will place abstract findings from ASCO2021 into clinical context and discuss how the results may change the current standard of care.
Conference highlights:
- Innovative and integrated learning environment.
- Audience response system
- Core competencies covered include patient care/patient-centered care, medical knowledge, system-based practice, and practice-based learning and improvement.
- Opportunities to network with colleagues and interact with faculties; enduring materials allow learners opportunities to learn at their convenience.
- Program topics can immediately be applied to clinical practice.
If you have difficulty registering for this meeting, please email – support@binayfoundation.org
Registration fees:
*Early bird registration deadline: July 12, 2021. Registration fees will increase by $100 at 9 AM on July 13, 2021.
Physicians (MD/DO) - $300
Non-Physician (RN/NP/PA/PharmD) - $150
Residents/Fellows - Free registration - see instructions below*
*If you are a resident or fellow in the United States, please create a user account on this portal using your work email, and send us an email from the email address used to create the account with the name of the conference(s) that you are interested in attending, and we will register you for free.
*If you are a resident or fellow from outside the United States, please create a user account on this portal using your work email if available, and send us an email from the email address used to create the account with the following information, and we will register you for free.
- Name of the conference(s) that you are interested in attending
- A picture ID or another document showing proof of your status as Resident/Fellow/Physician in training
- Name and email address of program director to verify your trainee status
Non-displaying industry representative - $600
Displaying industry representative (not covered by the display fee) - $500
If you are employed by the industry, you must register as "Industry representative" even if you are a licensed healthcare provider not involved in the sales of a product. The industry price is applicable to everyone who are employed by an ACCME defined ineligible company.
Acknowledgement of Commercial Support
This activity has been supported with Independent Medical Education Grants from the following companies:
Bristol-Myers Squibb
Seagen Inc.
Pfizer, Inc.
Target Audience
- Hematologists/Oncologists
- Oncology Nurse Practitioners
- Oncology Pharmacists
- Oncology Physician Assistants
- Oncology Fellows/Residents
- Oncology Nurses
- Researchers and others involved in the care of cancer patients
Learning Objectives
At the conclusion of the activity, participants will be able to:
- Discuss new and updated treatment options for patients with hematologic malignancies and solid tumors
- Identify side effects, indications, and contra-indications of therapies used to diagnose and treat cancers
- Explain how to effectively manage side-effects associated with cancer treatment
- Review abstracts presented at ASCO® 2021 and discuss their application in clinical settings
PARKING:
The hotel is asking anyone not staying at the hotel to park at the Olympic Parking structure at the corner past the hotel.
Binaytara Foundation's Fundraising Gala on 7/24/21
Our Annual Fundraising Gala Dinner is being held on the first day of this meeting - Saturday, July 24, 2021 at the same venue.
More information about the fundraising gala dinner can be found here - https://gala.binayfoundation.org
All times are listed in Pacific Standard Time (PST)
July 24, 2021
08:00 – 09:15 Lymphoid malignancies: Moderator - Dr. Christina Poh
Updates in lymphoma – 30 minutes - Dr. Ranjana Advani
Updates in CLL – 30 minutes - Dr. P Venugopal
Rapid fire Q&A – 15 minutes - Dr. David Aboulafia
09:15 – 10:30 Hematologic malignancies session: Moderator - Dr. Jacob Appelbaum
Management of multiple myeloma – 30 minutes - Dr. Shaji Kumar
Acute leukemia – new updates – 30 minutes - Dr. Jacob Appelbaum
Rapid fire Q&A – 15 minutes - Dr. Andrew Cowan
10:30 – 11:15 Break & Exhibits
*Breakfast & Learn- Non-CME Session in Parkside Room (2nd Floor) - Presented by Regeneron
with - Martin Dietrich, MD, PhD, AdventHealth Medical Group Cancer Institute Orlando
Topic - New FDA-approved first line monotherapy option in advanced NSCLC
*This activity is not a part of the licensed ASCO Direct™ Highlights.
11:15 – 12:30 Lung cancer session: Moderator - Dr. Cristina Merkhofer
Recent updates in NSCLC – 30 minutes - Dr. Jack West
Small cell lung cancer - 30 minutes - Dr. Rafael Santana-Davila
Rapid fire Q&A – 15 minutes - Dr. Joe Rosales
12: 30 – 13:15 Lunch/Break/Exhibits
*Lunch & Learn - Non- CME Session in Parkside Room (2nd Floor) - Presented by Pharmacyclics
with - Ryan Jacobs, MD of Levine Cancer Institute, Charlotte, NC
Topic - Redefining Approaches in Frontline Chronic Lymphocytic Leukemia (CLL) Treatment
*This activity is not a part of the licensed ASCO Direct™ Highlights
13:15 – 15:00 Women’s cancer Moderator - Dr. Fengting Yan
Non-metastatic breast cancer – 30 minutes - Dr. Siddhartha Yadav
Metastatic breast cancer - 30 minutes - Dr. Mark Pegram
Gynecologic malignancies – 30 minutes - Dr. Kalyan Banda
Q & A – 15 minutes
15:00 – 15:15 Break
15:15 – 16:30 General Oncology session
Sarcoma updates – 30 minutes - Dr. Michael Wagner
Brain tumor updates – 30 minutes - Dr. Vyshak Venur
Q & A – 15 minutes
Evening Program - 7/24/21
The Binaytara Foundation's Fundraising Gala Dinner will be held on 7/24/21 at the same venue (Crowne Plaza Downtown Seattle). Doors will open at 6:30 PM.
All registered attendees of this meeting are eligible to attend the gala dinner with no additional cost. However, you must RSVP by 7/10/21 to receive the free ticket. If you would like to bring a company or want to reserve the table, please select the appropriate option for tickets during registration for this meeting. More information about the fundraising gala can be found here - https://gala.binayfoundation.org
July 25, 2021
07:00 – 08:00 Registration and Breakfast
08:00 – 09:45 GI cancer session: Moderator - Dr. Lindsay Hannan
Updates in management of colon cancer – 30 minutes - Dr. Stacey Cohen
Management of upper GI malignancies – 30 minutes - Dr. Glynn Gilcrease
Pancreatic cancer and neuroendocrine carcinoma – 30 minutes - Dr. Andrew Coveler
Rapid fire Q&A – 15 minutes - Dr. Sakti Chakrabarti
9:45 – 10:30 Break & Exhibits
*Breakfast & Learn - Non-CME Session in Parkside Room (2nd Floor) - Presented by Exelixis
with - Sandy T. Liu, MD, University of California Los Angeles (UCLA)
Topic - CABOMETYX® + OPDIVO®: A New Combination Treatment for 1L Patients With Advanced Renal Cell Carcinoma
*This activity is not a part of the licensed ASCO Direct™ Highlights
10:30 – 12:15 General oncology session
Bladder cancer and prostate cancer – newer updates – 30 minutes - Dr. Neeraj Agarwal
Kidney cancer updates - 20 minutes - Dr. Scott Tykodi
Head and neck cancer – 20 minutes - Dr. Cristina Rodriguez
Skin cancers – new updates – 20 minutes - Dr. Shailender Bhatia
Discussion – 15 minutes
Parking on the day of the meeting:
The hotel is asking anyone not staying at the hotel to park at the Olympic Parking structure at the corner past the hotel. Very accessible and can accommodate everyone. Hotel’s valet will not be able to get everyone parked and out without HUGE wait. This will make everyone’s experience much better parking there.
Information provided by the hotel: Crowne Plaza Seattle is located in the heart of Downtown Seattle. We are located 14 miles from the Seattle-Tacoma International Airport. The Link Light Rail runs every 15 minutes and drops off only three blocks from the Hotel. The cost is $3.25 one-way. Direct bus services are available to and from the airport via the Grayline Downtown Airporter, which stops every half-hour at the hotel. Charges for the shuttle are $15.00 one-way and $25.00 round trip.
Accommodations
We have reserved a limited number of rooms at a discounted group rate for participants of ASCO Direct™ Highlights at Crowne Plaza Seattle Downtown. Please reserve your hotel room by June 23, 2021 to qualify for this rate. All rooms reserved under the group rate come with complimentary wifi in guest rooms.
Discounted Nightly Rates:
- General Rooms - $159/night + taxes
- Executive Suites - $209/night + taxes
You must mention ASCO Review or ASCO Direct™ Highlights to receive the discounted nightly rates.
Reserve your hotel room here - ASCO Direct™ Highlights Booking Link or by calling 888-233-9527.
Day Parking for local attendees who will not stay at the hotel: Daily Parking rate for conference attendees ( this is not an overnight parking rate) - $18/day
 | Shaji Kumar, MDProfessor of Medicine Mayo Clinic |  | Program ChairShailender Bhatia, MDAssociate Professor University of Washington Medical Oncologist Seattle Cancer Care Alliance |
 | David Aboulafia, MDMedical Oncologist/Hematologist Virginia Mason |  | Mark Pegram, MDProfessor of Medicine Stanford University |
 | Siddhartha Yadav, MDMedical Oncologist Mayo Clinic |  | Sakti Chakrabarti, MDAssociate Professor of Medicine Medical College of Wisconsin |
 | Jack West, MDMedical Oncologist City of Hope |  | Parameswaran Venugopal, MD Professor of Medicine & Director - Section of Hematology Rush University |
 | Ranjana Advani, MDMedical Oncologist Stanford University | ||
 | Andrew Cowan, MDAssistant Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance |  | Cristina Rodriguez, MDAssociate Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance |
 | Fengting Yan, MDMedical Oncologist Swedish Medical Center |  | Andrew Coveler, MDAssociate Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance |
 | Neeraj Agarwal, MDProfessor of Medicine University of Utah, Huntsman Cancer Institute |  | Rafael Santana-Davila, MDAssociate Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance |
 | Michael Wagner, MDAssistant Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance |  | Kalyan Banda, MDAssistant Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance |
 | Vyshak Venur, MDAssistant Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance |  | Cristina Merkhofer, MDAssistant Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance |
 | Stacey Cohen, MDAssociate Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance |  | Jacob Appelbaum, MD, PhDMedical Oncologist Seattle Cancer Care Alliance |
 | Scott Tykodi, MDAssociate Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance |  | Christina Poh, MDAssistant Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance |
 | Glynn Gilcrease III, MDAssistant Professor of Medicine University of Utah, Huntsman Cancer Institute |  | Joseph Rosales, MDMedical Oncologist/Hematologist Virginia Mason |
 | Lindsay Hannan, MDClinical Assistant Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance |
DISCLOSURES:
No Members of this activity's planning committee or faculty have any relevant financial relationship with an ineligible entity except for the following faculties. All conflicts have been mitigated.
Shaji Kumar, MD
Research support/Grant: Abbvie, Amgen, BMS, Carsgen, Janssen, KITE, Merck, Astra-Zeneca, Novartis, Roche-Genentech, Takeda, Tenebio
Consulting/Advisory Board participation: (with no personal payments) Abbvie, Amgen, BMS, Janssen, Roche-Genentech, Takeda, KITE, Astra-Zeneca, Bluebird Bio, and (with personal payment) Oncopeptides, Beigene, Antengene
Shailender Bhatia, MD
Research support/Grant to institution: EMD Serono, Merck, BMS, NantKwest, Novartis, Nektar, Exicure, Checkmate Pharma, Xencor
Consultant (advisory board with honoraria): BMS, Sanofi-Regeneron, EMD-Serono, Genentech
Mark Pegram, MD
Consultant: Pfizer, Eli Lilly, Novartis, Genentech/Roche, AstraZeneca
Sakti Chakrabarti, MD
Consultant - HalioDx, QED Therapeutics, DAVA Oncology,
Grant/Research Support - MERCK, Taiho Pharmaceutical, Roche Tissue
Diagnostics, Natera Inc..
Howard Jack West, MD
Consultant: Amgen, AstraZeneca, Genentech/Roche, Merck, Mirati, Regeneron
Speaker Bureau: Merck, AstraZeneca
Andrew Cowan, MD
Research support/Grant: Janssen, Bristol Myers Squibb, Abbvie, Sanofi Aventis, Harpoon
Consultant: Janssen, Abbvie, Cellectra, Sanofi, GSK
Cristina Rodriguez, MD
Research support/Grant: AstraZeneca, Ayala, Bristol Myers Squibb, Cue Biopharma, Kura, Merck
Consultant: Cue Biopharma
Andrew Coveler, MD
Research support/Grant: Actuate, Amgen, Medimmune
Consultant: Novocure, Seagen, Surface
Neeraj Agarwal, MD
Consultant: Astellas, AstraZeneca, Aveo, Bayer, BMS, Calithera, Clovis, Eisai, Eli Lilly, EMD Serono, Exelixis, Foundation Medicine, Genenetech, Janssen, Merck, MEI Pharma, Nektar, Novartis, Pfizer, Pharmacyclics, Seattle Genetics
Rafael Santna-Davila, MD
Consultant: Genentech, Bayer, NGM Biopharmaceuticals, Takeda, Lilly, AstraZeneca, Culinan Oncology, BMS
Research Support to Institution: Bayer, AstraZeneca, Genentech, Lilly, BeyondSPring Pharmaceuticals, ISA Pharmaceuticals, Abbvie
Michael Wagner, MD
Consultant: Adaptimmune, Deciphera
Research support/Grant: Adaptimmune, Deciphera, Athenex, GSK, Inhibrx, Incyte
Vyshak Alva Venur, MD
Consultant: Seagen
Stacy Cohen, MD
Consultant: Natera
Scott Tykodi, MD
Consultant: Exelixis, Merck, BMS, Intellisphere
Research Support/Grant: BMS, Genentech, Pfizer, Nektar Therapeutics, Merck, Exelixis, Jounce Therapeutics
Ranjana Advani, MD
Commercial Interest(s): Agensys, Relationship: Research support/Grant
Commercial Interest(s): Celgene, Relationship: Research support/Grant
Commercial Interest(s): Genentech/Roche, Relationship: Research support/Grant
Consultant: iDMC
Commercial Interest(s): Forty Seven/Gilead, Relationship: Research support/Grant
Commercial Interest(s): Janssen Pharmaceuticals, Relationship: Research support/Grant
Commercial Interest(s): Kura, Relationship: Research support/Grant
Consultant
Commercial Interest(s): Merck, Relationship: Research support/Grant
Consultant
Commercial Interest(s): Millenium, Relationship: Research support/Grant
Commercial Interest(s): Pharmacyclics, Relationship: Research support/Grant
Commercial Interest(s): Regeneron, Relationship: Research support/Grant
Commercial Interest(s): Seattle Genetics, Relationship: Research support/Grant, Please list if you selected other):
Commercial Interest(s): Cytier Therapeutics, Relationship: Research support/Grant
Commercial Interest(s): Incyte, Relationship: Consultant
Commercial Interest(s): Gilead, Relationship: Consultant
Commercial Interest(s): Bristol Myers Squibb/Celgene, Relationship: Consultant
Commercial Interest(s): BeiGene Ltd, Relationship: Consultant
Commercial Interest(s): Daiichi Sankyo, Relationship: Consultant
Commercial Interest(s): Sanofi, Relationship: Other
Commercial Interest(s): Takeda, Relationship: Other: CME
Commercial Interest(s): Karyopharm, Relationship: Consultant
Commercial Interest(s): ADC Therapeutics, Relationship: Consultant
The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.
The Binaytara Foundation designates this live activity for a maximum of 10.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 10.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
Nursing Contact Hours: Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 10.25 Contact Hours.
ABSM Maintenance of Certificate Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Available Credit
- 10.25 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 10.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 10.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 0.00 Attendance
- 10.25 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 10.25 Contact Hours.
Visit the Exhibits in Yellowstone Room & Carlsbad Room (Downstairs) to learn about all the new developments happening in the field of cancer treatment and for a chance to win a Fire HD 8 tablet, 8" HD display, 32 GB, latest model (2020 release).
We would like to thank the following supporters and exhibitors of this meeting for their support!
All exhibit spaces at this meeting have been sold out. Please join us at our Hematology Review & Precision Oncology Conferences in Salt Lake City on October 2-3, 2021.
Exhibit Distribution List Sign up if you would like to receive information about sponsoring and supporting our future conferences.
Price
If you have difficulty registering for this meeting, please email – support@binayfoundation.org
Registration Fees:
The following registration fees apply until midnight on 7/12/2021. The fees will increase by $100 for each professional on 7/13/2021.
Physicians (MD/DO) - $300
Non-Physician (RN/NP/PA/PharmD) - $150
Residents/Fellows - Free registration - see instructions below*
*If you are a resident or fellow in the United States, please create a user account on this portal using your work email, and send us an email from the email address used to create the account with the name of the conference(s) that you are interested in attending, and we will register you for free.
*If you are a resident or fellow from outside the United States, please create a user account on this portal using your work email if available, and send us an email from the email address used to create the account with the following information, and we will register you for free.
- Name of the conference(s) that you are interested in attending
- A picture ID or another document showing proof of your status as Resident/Fellow/Physician in training
- Name and email address of program director to verify your trainee status
Non-displaying industry representative - $600
Displaying industry representative (not covered by the display fee) - $500
If you are employed by the industry, you must register as "Industry representative" even if you are a licensed healthcare provider not involved in the sales of product. The industry price is applicable to everyone who are employed by an ACCME defined ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients with the exception of hospitals and facilities that provide direct care to patients.
Cancellation Policy
You may cancel your enrollment at any time. cancellation fees apply as below:
- 50% of the regalar registration fee will be refunded if registration is cancelled by June 15, 2021.
- No refunds will be issued if registration is cancelled after that date.
No credits will be offered if you do not complete all required steps of this activity which include registration, participation in the live activity, and completion of pre & post tests as well as course evaluations.